Prevention of Rhesus-D Alloimmunization in the First Trimester of Pregnancy: Economic Analysis of Three Management Strategies.
Abortion
Alloimmunization
Anti-D immunoglobulin
Fetomaternal hemorrhage
Prophylaxis
Rhesus disease
Journal
Transfusion medicine reviews
ISSN: 1532-9496
Titre abrégé: Transfus Med Rev
Pays: United States
ID NLM: 8709027
Informations de publication
Date de publication:
14 Oct 2023
14 Oct 2023
Historique:
received:
19
06
2023
revised:
19
09
2023
accepted:
28
09
2023
medline:
5
11
2023
pubmed:
5
11
2023
entrez:
4
11
2023
Statut:
aheadofprint
Résumé
Anti-D alloimmunization in the first trimester of pregnancy has long been the subject of prevention with anti-D immunoglobulins during events at risk of fetomaternal hemorrhage. Although the efficacy of preventing anti-D alloimmunization by an injection of immunoglobulin at 28 weeks of gestation (WG) is obvious, the literature provides little evidence of the effectiveness before 12
Identifiants
pubmed: 37925226
pii: S0887-7963(23)00068-8
doi: 10.1016/j.tmrv.2023.150778
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
150778Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.